Stage III Breast Cancer Completed Phase Trials for Vorinostat (DB02546)

IndicationStatusPhase
DBCOND0031775 (Stage III Breast Cancer)CompletedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00262834Vorinostat in Treating Women Who Are Undergoing Surgery For Newly Diagnosed Stage I -III Breast CancerTreatment